NICE is committed to promoting equality of opportunity, eliminating unlawful discrimination and fostering good relations between people with particular protected characteristics and others.
CytoSorb is intended for use in people having urgent or emergency cardiac surgery. Older people, people who are male, and people with diabetes, high blood pressure or obesity are more likely to develop coronary heart disease. People of South Asian family origin are more likely to develop coronary heart disease. People of African or African Caribbean family origin are at higher risk of developing high blood pressure and having a stroke. People of African, African Caribbean and South Asian family origin are more likely to develop type 2 diabetes. CytoSorb is contraindicated in some health states that may, next to acute critical care scenarios, also occur in chronic conditions. This may include, for example, people with a very low platelet count, people having immunosuppressive therapy (except for corticosteroids), people with acute sickle cell crisis, or people who have severely suppressed immune systems in the context of chronic diseases. People with chronic conditions may be considered disabled. CytoSorb is partially contraindicated for people who are, or may be, pregnant. Age, disability, sex, race, and pregnancy and maternity are protected characteristics under the Equality Act (2010).